Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Extraovarian peritoneal serous papillary carcinoma mimicking colonic obstruction
1Second Department of Surgery, Greece
2Department of Pathology, Areteion University Hospital, Athens Medical School, Athens, Greece
*Corresponding Author(s): T. Theodosopoulos E-mail: theodosios@panafonet.gr
Involvement of the colon by extraovarian peritoneal serous papillary carcinoma (EPSPC) is considered as rare. During a 10-year period the records of five female patients with it mean age of 73.4 years who were admitted for colonic obstruction due to EPSPC were reviewed. Preoperative and postoperative data were studied. All patients presented with symptoms of colonic obstruction and high concentrations of CA-125. Involvement of the sigmoid colon was demonstrated preoperatively both in CT and colonoscopy. Operative findings of multiple peritoneal implantations involving the surface of the ovaries in two cases, the greater omentum in three cases and invasion of the sigmoid colon in all cases prompted LIS to perform sigmoidectomy and omentectomy in all cases with bilateral salpingo-oophorectomy in four of them. All patients received adjuvant paclitaxel plus platinum-based combination chemotherapy.
Extraovarian peritoneal serous papillary carcinoma; Staging; Surgery; Chemotherapy
T. Theodosopoulos,A. Marinis,A. Yiallourou,N. Dafnios,A. Kondi-Pafiti,I. Vassiliou,V. Smyrniotis,K. Karapanos. Extraovarian peritoneal serous papillary carcinoma mimicking colonic obstruction. European Journal of Gynaecological Oncology. 2008. 29(5);502-504.
[1] Sherdlow M.: “Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary”. Am. J. Obstet. Gynecol., 1959, 77, 197.
[2] Feuer G.A., Shevchuk M., Calanog A.: “Normal-sized ovary carcinoma syndrome”. Obstet. Gynecol., 1989, 73, 786.
[3] Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L. et al.: “New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada”. J. Natl. Cancer. Inst., 2000, 92, 205.
[4] Andersen J.R., Gerardy R.: “Novak’s Gynecology, Anatomy and Embryology”. In: Berek J.S. (ed.), Novak’s Gynecology, Philadelphia, Lippincott Williams & Wilkins, 2000, 69.
[5] Bloss J.D., Liao S.Y., Buller R.E., Manetta A., Berman M.L., McMeekin S. et al.: “Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary”. Gynecol Oncol., 1993, 50, 347.
[6] Dalrymple J.C., Bannatyne P., Russell P., Solomon H.J., Tattersall M.H., Atkinson K. et al.: “Extraovarian peritoneal serous papillary carcinoma: A clinicopathological study of 31 cases”. Cancer, 1989, 64, 110.
[7] Fromm G.L., Gershenson D.M., Silva E.G.: “Papillary serous carcinoma of the peritoneum”. Obstet. Gynecol., 1990, 75, 89.
[8] Ben-Baruch G., Sivan E., Moran O., Rizel S., Menezer J., Seidman D.S.: “Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with Stage III-IV ovarian papillary serous carcinoma”. Gynecol. Oncol., 1996, 60, 393.
[9] Mills S.E., Andersen W.A., Fechner R.E., Austin M.B.: “Serous surface papillary carcinoma: A clinicopathological study of 10 cases and comparison with stage III- IV ovarian serous carcinoma”. Am. J. Surg. Pathol., 1988, 12, 827.
[10] Altaras M.M., Aviram R., Cohen I., Cordoba M., Weiss E., Beyth Y.: “Primary peritoneal papillary serous adenocarcinoma: clinical and management aspects”. Gynecol. Oncol., 1991, 40, 230.
[11] Ayhan A., Taskiran C., Yigit-Celik N., Bozdag G., Gultekin M., Usubutun A., et al.: “Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer?”. Int. J. Gynecol. Cancer, 2006, 16, 484.
[12] Halperin R., Zehavi S., Langer R., Hadas E., Bukovsky I., Schneider D.: “Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer”. Int. J. Gynecol. Cancer, 2001, 11, 403.
[13] Killackey M.A., Davis A.R.: “Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma”. Gynecol. Oncol., 1993, 51, 171.
[14] Chu C.S., Menzin A.W., Leonard D.G.B., Rubin S.C., Wheeler J.E.: “Primary peritoneal carcinoma: a review of the literature”. Obstet. Gynecol. Surv., 1999, 54, 323.
[15] Taus P., Petru E., Gucer F., Pickel H., Lahousen M.: “Primary serous papillary carcinoma of the peritoneum: a report of 18 patients”. Eur. J. Gynaecol. Oncol., 1997, 18, 171.
[16] Dubernard G., Morice P., Rey A., Camatte S., Fourchotte V., Thoury A. et al.: “Prognosis of stage III or IV primary peritoneal serous papillary carcinoma”. Eur. J. Surg. Oncol., 2004, 30, 976.
[17] Ransom D.T., Patel S.R., Keeney G.L., Malkasian G.D., Edmonson J.H.: “Papillary serous carcinoma of the peritoneum: a review of 33 cases treated with platin-based chemotherapy”. Cancer, 1990, 66, 1091.
Top